CD4 and neoplasm: performed scRNA-seq analysis on 3110 peripheral T cells of NSCLC patients before and after the initiation of PD-1 blockade and found a higher cytotoxic activity in tumor-related CD4+ T-cell clones than in CD8+ T-cell clones (23).